PE-001(Shenyang Haiwang Biotechnology/China Pharmaceutical University)

N/A

Report date: 2025/03/12 17:00:08
NME

Base Information

Drug NamePE-001(Shenyang Haiwang Biotechnology/China Pharmaceutical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsAdenosine A1 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorAdenosine A1 receptor
Therapy Area/IndicationsPremature Ejaculation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenyang Haiwang Biotechnology Co LtdChina Pharmaceutical University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLiaoning Green Biopharmaceutical Group Co LtdShenyang Haiwang Biotechnology Co LtdChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsPremature Ejaculation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A